hrs-2129
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Oct 17, 2024 (NCT06619392)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07185594 | Phase 2/Phase 3 (Phase 3) | Oct 24, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06780267 | Phase 1 | Feb 15, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06742840 | Phase 1 | Dec 31, 2024 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06619392 | Phase 1 | Oct 17, 2024 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 4 | 4 | 2 | 2024 |
1 organizations
Page 1 / 1